About
Merida Biosciences Inc is a biotechnology company focused on developing precision therapeutics for serious autoimmune and allergic diseases. Recently, it has been in the news due to its acquisition by Eli Lilly and Company for up to $2.875 billion, which highlights its significant role in the biotech sector.
Focus
Life Sciences
Lease
Markets
Headquarters
500 Technology Square
FAQs
Merida Biosciences Inc has financed 1 deal.
Merida Biosciences Inc's most recent deal was on October 16, 2026.
Member since: October 2026
Deals
Transaction Type
Asset Type
State
Sort By
LEASED
Adam Townsend Of Merida Biosciences Inc Subleases 34,500 SF At 200 Arsenal Yards Boulevard Watertown MA
200 Arsenal Yards Boulevard, Watertown, MA
MACRE
MD
AT
Oct 16, 2026